Results 21 to 30 of about 4,182 (143)
Rapidly Declining SARS-CoV-2 Antibody Titers within 4 Months after BNT162b2 Vaccination
Vaccines, 2021 The efficacy and safety of the BNT162b2 vaccine are known, but antibodies are expected to decrease over time after vaccination. We collected blood samples from 104 fully vaccinated health care workers at 3 and 5 weeks after first vaccination and 4 months
Dong-Ho Jo +6 more
doaj +1 more source
Biomaterial‐based gene therapy
MedComm, Volume 4, Issue 3, June 2023., 2023 Overview of biomaterial‐based delivery systems for gene therapy. Abstract Gene therapy, a medical approach that involves the correction or replacement of defective and abnormal genes, plays an essential role in the treatment of complex and refractory diseases, such as hereditary diseases, cancer, and rheumatic immune diseases.
Yi Yu +8 more
wiley +1 more source
Vaccines, 2023 People with HIV (PWH) may be more susceptible to SARS-CoV-2 infection and worse clinical outcomes. We investigated the disparity in SARS-CoV-2 vaccination coverage between PWH and those without HIV (PWoH) in Catalonia, Spain, assessing primary and ...
Daniel Kwakye Nomah +16 more
doaj +1 more source
Acquired hemophilia A (AHA) due to anti‐SARS‐CoV‐2 vaccination: A systematic review
eJHaem, Volume 4, Issue 2, Page 532-543, May 2023., 2023 Abstract Vaccination against SARS‐CoV2 has been the largest vaccination campaign over the past two decades. The aim of this study is to qualitatively assess the reported cases of acquired hemophilia A (AHA) that developed after COVID‐19 vaccination to further elaborate on incidence, presentation, treatment, and outcomes.We queried Medline (PubMed ...
Fnu Amisha +3 more
wiley +1 more source
Journal of Cosmetic Dermatology, Volume 22, Issue 4, Page 1152-1156, April 2023., 2023 Abstract Background Coronavirus disease 2019 (COVID‐19) has given rise to several new onset or exacerbated dermatologic disorders including vitiligo. Aim and Method Here, we present different aspects of relationship between SARS‐CoV‐2 infection or its associated vaccines and vitiligo and aim to provide solutions to overcome the potential challenges ...
Zeinab Aryanian +5 more
wiley +1 more source
EBioMedicine, 2023 Summary: Background: Vaccination reduces COVID-19-related hospitalization among older adults. However, how SARS-CoV-2 infection and vaccine regimens affect vaccine-elicited immunity remain unclear.
Carol Ho-Yan Fong +11 more
doaj +1 more source
Infection by SARS‐CoV‐2 with alternate frequencies of mRNA vaccine boosting
Journal of Medical Virology, Volume 95, Issue 2, February 2023., 2023 Abstract One of the most consequential unknowns of the COVID‐19 pandemic is the frequency at which vaccine boosting provides sufficient protection from infection. We quantified the statistical likelihood of breakthrough infections over time following different boosting schedules with messenger RNA (mRNA)‐1273 (Moderna) and BNT162b2 (Pfizer‐BioNTech ...
Jeffrey P. Townsend +2 more
wiley +1 more source
Bulletin of the National Research Centre, 2021 Background High effectiveness of COVID-19 vaccines is essential for the pandemic control. This study systematically reviewed available evidence on effectiveness of ChAdOx1 and BNT162b2 vaccines in the general population, for improved vaccine policies and
Chinonyerem O. Iheanacho +2 more
doaj +1 more source
Journal of Medical Virology, Volume 95, Issue 1, January 2023., 2023 Abstract Evidence about the long‐term persistence of the booster‐mediated immunity against Omicron is mandatory for pandemic management and deployment of vaccination strategies. A total of 155 healthcare professionals (104 COVID‐19 naive and 51 with a history of SARS‐CoV‐2 infection) received a homologous BNT162b2 booster.
Julien Favresse +8 more
wiley +1 more source
Journal of Immunology Research, Volume 2023, Issue 1, 2023., 2023 January 2022 onward, India witnessed a sudden increase in Omicron COVID‐19 infections, having a mild course that prompted us to identify the key host factors/immune molecules modulating disease course/outcomes. The current study evaluated the percentages of lymphocyte subsets by flowcytometry, SARS‐CoV‐2 specific T‐cell immune response by ELISPOT ...
Pragya D. Yadav +11 more
wiley +1 more source